Keryx Biopharmaceuticals (NASDAQ:KERX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Recs

0
Player Avatar pchop123 (76.56) Submitted: 7/18/2012 10:16:33 AM : Underperform Start Price: $1.91 KERX Score: +5.47

Look for more downside here

Featured Broker Partners


Advertisement